Our results demonstrate that QKI inhibits lung cancer cell growth at least in part through regulating the alternative splicing of the Notch pathway regulator NUMB. Moreover, we show that QKI can inhibit splicing by selectively competing with a core splicing factor SF1 for targeting an authentic splicing signal, the branchpoint. This evidence concerns the gene NUMB and lung carcinoma.